In the year 2020, an estimate of 2.2 million people has been diagnosed with lung cancer. It is the second most commonly diagnosed cancer and is among leading cause of cancer deaths….
Category: Lung Cancer Treatment
Get to know about types of lung cancer treatment methods, causes, researches, early symptoms and stages. To know more details about the lung cancers browse the website.
NICE Approves Combination Therapy for Squamous Non-Small Cell Lung Cancer
There are mainly two different groups of lung cancer: non-small cell lung cancer and small cell lung cancer. These groups can further be split into more groups depending on where and how…
Healthy Habits to Follow During and After Lung Cancer Treatment
When lung cancer is diagnosed, a person goes through various mental and financial challenges. One needs to maintain a healthy lifestyle to stay well during and after lung cancer treatment. By developing…
US FDA Approves Roche’s Tecentriq as Adjuvant Treatment for Early NSCLC
The US Food and Drug Administration (FDA) has approved Roche’s Tecentriq or atezolizumab as adjuvant treatment for patients with Stage II-IIIA non-small cell lung cancer (NSCLC) whose tumors express PD-L1=1%, as determined…
Lung Cancer Treatment May Impact Daily Function in Elderly Patients
According to the new research published in Journal of the American Geriatrics Society, older adults with lung cancer may experience decline in life-space mobility during lung cancer treatment. The study has been…
Study Finds New Possibilities for Lung Cancer Treatment in ‘Never Smokers’
Smoking is the well-known reason for causing lung cancer among a significant amount of people. But, there are also those lung cancer patients who have never smoked in their life but still…
Robotic Surgery for Lung Cancer: What You Need to Know
In today’s article, we are taking a close look at robotic surgery for lung cancer. Robotic lung surgery was introduced back in 2002 and the technique is called as RATS which is…
Takeda’s Exkivity Approved by FDA for Rare form of Lung Cancer
Takeda Pharmaceutical Co. Ltd. becomes the first one to get FDA approval for an oral drug targeted against rare form of non-small cell lung cancer. FDA has approved Exkivity (mobocertinib) for treatment…